{
    "2021-08-17": [
        [
            {
                "time": "",
                "original_text": "成功分离德尔塔毒株！康泰生物能否率先破局？",
                "features": {
                    "keywords": [
                        "德尔塔毒株",
                        "康泰生物",
                        "疫苗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "干货！2021年中国疫苗行业龙头分析——沃森生物：致力于中国第一mRNA疫苗",
                "features": {
                    "keywords": [
                        "疫苗",
                        "沃森生物",
                        "mRNA疫苗"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "73股获券商买入评级 康泰生物目标涨幅达65.65%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "康泰生物",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股分化加剧，4大类外资在持续行动，长远布局正当其时",
                "features": {
                    "keywords": [
                        "A股",
                        "外资",
                        "持续行动",
                        "长远布局"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}